Published in Parkinsonism Relat Disord on April 23, 2008
Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling. Chaos (2009) 1.81
Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. Chem Biol (2011) 1.16
Wearability assessment of a wearable system for Parkinson's disease remote monitoring based on a body area network of sensors. Sensors (Basel) (2014) 1.07
Feasibility study of a wearable system based on a wireless body area network for gait assessment in Parkinson's disease patients. Sensors (Basel) (2014) 0.93
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA J (2013) 0.89
Gender effect on time to levodopa-induced dyskinesias. J Neurol (2011) 0.85
Tea and health: preventive and therapeutic usefulness in the elderly? Curr Opin Clin Nutr Metab Care (2009) 0.85
Pu-Erh tea and GABA attenuates oxidative stress in kainic acid-induced status epilepticus. J Biomed Sci (2011) 0.84
Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies. PLoS One (2010) 0.82
Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration. Brain Res (2012) 0.80
Novel therapeutic strategies in Parkinson's disease. Eur J Clin Pharmacol (2009) 0.79
Can the disease course in Parkinson's disease be slowed? BMC Med (2015) 0.77
Does tea consumption correlate to risk of fracture? A meta-analysis. Int J Clin Exp Med (2015) 0.76
Tea consumption didn't modify the risk of fracture: a dose-response meta-analysis of observational studies. Diagn Pathol (2014) 0.75
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
The role of executive function and attention in gait. Mov Disord (2008) 5.03
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord (2004) 4.83
Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord (2004) 4.48
Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding? Eur J Neurosci (2005) 2.73
Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol (2011) 2.65
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology (2013) 2.64
Dual-tasking effects on gait variability: the role of aging, falls, and executive function. Mov Disord (2006) 2.62
Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Exp Brain Res (2005) 2.61
A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet (2008) 2.58
Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci (2003) 2.37
Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling. J Gerontol A Biol Sci Med Sci (2010) 2.19
Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease? Med Eng Phys (2009) 2.16
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord (2013) 2.01
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet (2008) 1.95
Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain (2008) 1.94
PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet (2012) 1.91
Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol (2007) 1.80
Effects of cognitive challenge on gait variability in patients with Parkinson's disease. J Geriatr Psychiatry Neurol (2003) 1.80
Red flags for multiple system atrophy. Mov Disord (2008) 1.75
Executive cognitive deficits in primary dystonia. Mov Disord (2003) 1.69
Dual-task decrements in gait: contributing factors among healthy older adults. J Gerontol A Biol Sci Med Sci (2008) 1.66
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet (2003) 1.65
How does explicit prioritization alter walking during dual-task performance? Effects of age and sex on gait speed and variability. Phys Ther (2009) 1.62
A common cognitive profile in elderly fallers and in patients with Parkinson's disease: the prominence of impaired executive function and attention. Exp Aging Res (2006) 1.60
Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease. Eur J Neurosci (2006) 1.59
Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture (2009) 1.59
Gait asymmetry in patients with Parkinson's disease and elderly fallers: when does the bilateral coordination of gait require attention? Exp Brain Res (2007) 1.58
Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit. Mov Disord (2003) 1.58
Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition. PLoS One (2012) 1.57
Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study. Arch Phys Med Rehabil (2007) 1.55
Rhythmic auditory stimulation modulates gait variability in Parkinson's disease. Eur J Neurosci (2007) 1.54
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord (2008) 1.50
A new measure for quantifying the bilateral coordination of human gait: effects of aging and Parkinson's disease. Exp Brain Res (2007) 1.50
Is freezing of gait in Parkinson's disease related to asymmetric motor function? Ann Neurol (2005) 1.49
The power of cueing to circumvent dopamine deficits: a review of physical therapy treatment of gait disturbances in Parkinson's disease. Mov Disord (2002) 1.42
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg (2011) 1.42
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease. Mov Disord (2005) 1.41
Properties of the 'timed up and go' test: more than meets the eye. Gerontology (2010) 1.40
Bilateral coordination of walking and freezing of gait in Parkinson's disease. Eur J Neurosci (2008) 1.37
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord (2010) 1.34
Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study. Clin Neuropharmacol (2006) 1.33
Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol (2011) 1.29
Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait. Mov Disord (2007) 1.28
Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease? J Gerontol A Biol Sci Med Sci (2010) 1.27
Computer-based, personalized cognitive training versus classical computer games: a randomized double-blind prospective trial of cognitive stimulation. Neuroepidemiology (2011) 1.26
Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord (2007) 1.26
Wearable assistant for Parkinson's disease patients with the freezing of gait symptom. IEEE Trans Inf Technol Biomed (2009) 1.25
Can methylphenidate reduce fall risk in community-living older adults? A double-blind, single-dose cross-over study. J Am Geriatr Soc (2008) 1.21
The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk? Expert Rev Neurother (2011) 1.21
Effect of gait speed on gait rhythmicity in Parkinson's disease: variability of stride time and swing time respond differently. J Neuroeng Rehabil (2005) 1.20
Do we always prioritize balance when walking? Towards an integrated model of task prioritization. Mov Disord (2012) 1.20
Assessing fear of falling: Can a short version of the Activities-specific Balance Confidence scale be useful? Mov Disord (2006) 1.20
Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a body-worn accelerometer. Neurorehabil Neural Repair (2011) 1.18
Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology (2013) 1.17
Does the evaluation of gait quality during daily life provide insight into fall risk? A novel approach using 3-day accelerometer recordings. Neurorehabil Neural Repair (2013) 1.14
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Mov Disord (2006) 1.13
Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Mov Disord (2007) 1.11
White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. Magn Reson Imaging (2005) 1.09
Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease. Mov Disord (2007) 1.06
Fluctuation and synchronization of gait intervals and gait force profiles distinguish stages of Parkinson's disease. Physica A (2007) 1.06
Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain (2002) 1.06
Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery (2004) 1.06
Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch Neurol (2012) 1.05
When does walking alter thinking? Age and task associated findings. Brain Res (2008) 1.05
Increased frontal brain activation during walking while dual tasking: an fNIRS study in healthy young adults. J Neuroeng Rehabil (2014) 1.04
A training program to improve gait while dual tasking in patients with Parkinson's disease: a pilot study. Arch Phys Med Rehabil (2011) 1.03
Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol (2002) 1.03
Obstacle avoidance to elicit freezing of gait during treadmill walking. Mov Disord (2010) 1.02
The Dynamic Gait Index in healthy older adults: the role of stair climbing, fear of falling and gender. Gait Posture (2008) 1.02
Effects of cognitive function on gait and dual tasking abilities in patients with Parkinson's disease suffering from motor response fluctuations. Exp Brain Res (2010) 1.01
Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol (2005) 1.00
Balance and gait in older adults with systemic hypertension. Am J Cardiol (2003) 1.00
Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the "ON" medication state. Exp Brain Res (2011) 1.00
Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord (2006) 0.99
Association between performance on Timed Up and Go subtasks and mild cognitive impairment: further insights into the links between cognitive and motor function. J Am Geriatr Soc (2014) 0.99
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol (2006) 0.98
Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study. Dement Geriatr Cogn Disord (2009) 0.98
Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia (2004) 0.98
White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes? PLoS One (2013) 0.98
Sexual dysfunction in Parkinson's disease. J Sex Marital Ther (2004) 0.98
The contribution of postural control and bilateral coordination to the impact of dual tasking on gait. Exp Brain Res (2013) 0.97
Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord (2010) 0.97
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol (2010) 0.96
The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice. Prog Neurobiol (2002) 0.96
Automated detection of near falls: algorithm development and preliminary results. BMC Res Notes (2010) 0.95
Interference to consolidation phase gains in learning a novel movement sequence by handwriting: dependence on laterality and the level of experience with the written sequence. Exp Brain Res (2007) 0.94
High rates and the risk factors for emergency room visits and hospitalization in Parkinson's disease. Parkinsonism Relat Disord (2013) 0.94
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry (2010) 0.94
Gait in attention deficit hyperactivity disorder : effects of methylphenidate and dual tasking. J Neurol (2007) 0.94
Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus. J Child Neurol (2013) 0.93
Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage (2004) 0.93
When practice does not make perfect: well-practiced handwriting interferes with the consolidation phase gains in learning a movement sequence. Exp Brain Res (2006) 0.93
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. J Neural Transm (Vienna) (2009) 0.93